§ 1.4 · Section 1 · Why leave the United States?

Is medical tourism safe?

The honest answer is: it depends on the procedure, the country, the facility, and how the trip was organized, none of which are the same question. This page separates the four variables so you can ask the right one about your own situation.

Prefer to watch?

It's the facility, not the country.

This page is a 9-minute read. The video covers the same ground: what actually drives safety abroad, and why the facility matters more than the country. Keep scrolling for the full breakdown.

Rather read? The full breakdown continues below
§ 1.4 · base-rate, side by side
Internationally accredited hospitalSame procedure
U.S. domestic equivalent
3%/12%
Unaccredited storefrontSame procedure
~4× the complication rate

"Mexico" is not the variable. The facility is the variable and the four-fold spread between the two columns is what the rest of this page is about.

Applied to Celva, the five-layer check returns,
01 · setting
Hospital, not clinic.
Hospital Angeles
national hospital certification · ICU on-site
02 · manufacturing
In-house cGMP lab.
COFEPRIS-supervised
Lot release on file
03 · physicians
Named, not "the team."
Named on every chart
Verifiable credentials
04 · pathway
Written SAE plan.
Admission rights
U.S. continuity
05 · cost floor
Itemized, above floor.
No bundled total
No discount marketing

The question hides four questions.

"Is medical tourism safe" averages across trips that have nothing in common: a routine dental crown, a bariatric sleeve at a budget clinic, a cell-therapy program at a internationally accredited hospital. The first is roughly as risky as having the work done at home. The second is documented to be worse. The third is its own category. The right question is never about medical tourism; it's about which quadrant.

§ Base rate, internationally accredited hospital

~3% complication.

Pooled complication rate for elective procedures at internationally accredited international hospitals, comparable to U.S. domestic for the same procedures.

§ Base rate, unaccredited clinic

~12% complication.

Self-reported complication rate from unaccredited cosmetic and bariatric facilities. Underreported; true number likely higher.

§ Variable that matters most

Facility, not country.

"Mexico" is not the variable. "Unaccredited Mexican strip-mall clinic" and "Hospital Angeles Tijuana" diverge by an order of magnitude.

Rates 01%The base-rate sketch

The headline number is misleading.

Most "medical tourism safety" articles report a single complication rate: usually somewhere between 2% and 15%: without specifying the procedure mix, the facility type, or the country. That number is almost useless. Below is a more honest decomposition: same procedures, different settings, with their actual reported rates side by side.

Figure 1.4.1 · Complication rates by setting (pooled industry data)

The same procedure, four different rooms.

U.S. domestic, accredited hospitalReference point
~3%baseline
internationally accredited international hospitalMexico, Thailand, Costa Rica
~3%equivalent
Unaccredited international clinicCosmetic / bariatric strip-mall
~12%4× baseline
Unregulated stem-cell clinic abroadNo COFEPRIS, no hospital license
7–18%varies wildly

Two observations. First, the accredited-hospital number matches the U.S.-hospital number: accreditation, not geography, is the equalizer. Second, the unaccredited clinic numbers reflect self-reported data; the true rates are almost certainly worse because adverse events at unregulated facilities are under-disclosed. The reasonable interpretation: a procedure done at an internationally accredited hospital abroad is statistically indistinguishable from the same procedure done at home; a procedure done at an unaccredited storefront anywhere, abroad or domestic, is several times riskier.

Vars 02Four variables, not one

The four levers that move the safety number.

Medical-tourism safety is best understood as a 2×2 grid: procedure complexity on one axis, facility quality on the other. The same country can house a clinic in every quadrant. The same procedure can be done in any quadrant. The quadrant is the unit of risk, not the country.

Figure 1.4.2 · The risk quadrants

Where the risk actually lives.

↑ More complex procedure
Q1 · Complex / Accredited
The defensible cell-therapy case.

COFEPRIS-licensed hospital, named physicians, in-house cGMP lab. Cardiac, neurological, autoimmune work falls here. Risk equivalent to U.S. domestic for the same procedure. This is where Celva sits.

Q2 · Complex / Unaccredited
Where the cautionary tales live.

Stem cells at a freestanding storefront, weight-loss surgery in a converted apartment, cosmetic surgery without a hospital across the street. Most of the bad stories you've read come from this quadrant. Avoid.

Q3 · Simple / Accredited
The low-stakes everyday case.

Dental work, routine elective surgery, IVF at a reputable clinic. Comparable risk to U.S. domestic. The "save 60% on a crown" segment of medical tourism. the part that works and rarely makes the news.

Q4 · Simple / Unaccredited
Penny-wise, pound-foolish.

Cheap dental at an unlicensed office, cosmetic injections at a spa, "stem cell vitamins." Usually fine because the procedure is forgiving; occasionally catastrophic when it isn't. The risk is mostly in the tail.

← Unaccredited facility
Accredited facility →

The instinctive reading of "medical tourism" averages across all four quadrants and reports the mean. That number is unhelpful because almost no patient is in the average, you're in a quadrant, and the quadrant matters more than the country. A complex procedure at an accredited facility is one of the safer choices in medicine, full stop. A complex procedure at an unaccredited facility is one of the more dangerous. The country name is a poor proxy for either.

Figure 1.4.2.1 · Where U.S. medical tourists actually go (2024)

Top destinations by U.S. patient volume, with the variables that matter.

#
Country
national hospital certification hosp.
Cost vs. US
Verdict
Why
1
Mexico~1.4M U.S. patients/yr
12
–60–75%
Quadrant-dependent
internationally accredited hospitals in CDMX, Monterrey, Tijuana, Guadalajara are excellent. Strip-mall clinics in the same cities are dangerous. The country name tells you nothing.
2
Thailand~450k U.S. patients/yr
63
–50–70%
Mostly strong
Bumrungrad and Bangkok Hospital are global benchmarks. Strong cardiac and orthopedic record. Less common for cell therapy.
3
Costa Rica~150k U.S. patients/yr
3
–40–60%
Mostly strong
Tight regulator + small set of accredited facilities. Strong for dental and routine surgery. Limited cell-therapy infrastructure.
4
India~120k U.S. patients/yr
39
–60–80%
Quadrant-dependent
Apollo and Fortis chains internationally accredited and high-volume for cardiac. Unregulated stem-cell market also present. Wide quality range, verify per facility.
5
Panama~70k U.S. patients/yr
2
–30–50%
Mostly strong
Punta Pacifica (national hospital certification) is well-regarded; Stem Cell Institute Panama is the major cell-therapy player. See §6.2.
6
Dominican Republic~60k U.S. patients/yr
0
–60–70%
Caution warranted
No internationally accredited hospitals. Major cosmetic-surgery destination with documented outbreaks (2014–18). Lower-cost, higher-risk profile.
7
Turkey~55k U.S. patients/yr
33
–50–70%
Quadrant-dependent
Strong private-network presence in Istanbul. Hair restoration and bariatric surgery dominate; quality varies dramatically by facility.
8
Cayman Islands~10k U.S. patients/yr
1
–10–30%
Strong, narrow
Health City Cayman (national hospital certification), destination for cardiac and orthopedic. Premium-priced "near-shore" alternative to Mexico.

The pattern is consistent with the quadrant analysis above. Countries with concentrated accredited capacity (Thailand, Costa Rica, Panama) skew toward "strong" outcomes; countries with thin accreditation density (Dominican Republic) show up in the cautionary tales. Mexico is the largest-volume destination, and Mexico is also the most heterogeneous twelve internationally accredited hospitals and several thousand unaccredited storefronts share the same border. The country isn't the variable; the facility within the country is.

Stack 03+The five-layer safety check

Five things to verify, about any cross-border offering.

The good news is that the variables are easy to check from the outside. If an offering passes all five of these, it is in Q1 of the quadrant, complex procedure at an accredited facility, and the base-rate complication number is statistically indistinguishable from doing the same thing at home. Failure on any one of the five demotes it. This is the test we want patients to apply to us, not just to other clinics.

Figure 1.4.4 · The five-layer check, applied to any cross-border medical offering

Each layer is a question they should answer in one sentence.

01
Hospital, not clinic.
The infusion or procedure happens inside a licensed hospital with imaging, an OR, and an ICU on the same campus. Not a strip-mall, not a converted office.
VerifyCOFEPRIS hospital license, international hospital accreditation
02
Manufacturing under regulator-visible cGMP.
Cells are made in a registered cGMP facility with inspections and release testing. Not "we get them from somewhere."
VerifyCOFEPRIS / ANMAT / equivalent license, lot release docs
03
Named physicians, not "our medical team."
You can find each physician by name, look up their training, and contact their office. "Our medical team" is a tell.
VerifyPhysician profiles with credentials, license numbers
04
Written SAE pathway.
There is a documented plan for what happens if you have a serious adverse event: admission rights, ICU coverage, evacuation, U.S. continuity. Ask for it.
VerifySAE protocol document, hospital admission agreement
05
Nothing below the cost floor.
A real cell-therapy program cannot be done on a bargain budget. If an offer is wildly below the cost of doing the work properly, the work isn't being done properly.
VerifyReceipt with line items, not a bundled total

If you apply this five-layer check to any clinic, ours or anyone else's, and any layer comes back ambiguous, the right move is to ask the question explicitly and read the answer carefully. A clinic that passes all five gives you the same risk profile as a U.S. hospital doing the same procedure. A clinic that fails one is a different conversation. A clinic that fails three is the cautionary tale waiting to be written.

Figure 1.4.4.1 · Patient checklist by trip phase

What to verify before, during, and after.

Before · T−30 to T−7
Verification work, done from home.
  • Confirm hospital licensure and accreditation. Look up the facility on its national regulator's registry (in Mexico, COFEPRIS and the Consejo de Salubridad General). Should take 60 seconds.
  • Look up each named physician. Medical board, training institution, current hospital affiliation.
  • Ask how serious adverse events are handled. A real program will walk you through admission rights, ICU coverage, and U.S. continuity on the call.
  • Get an itemized quote. Line items, not a bundled total.
  • Tell your U.S. PCP. So Day 1 back home isn't a cold start.
During · T0 to T+5
Verify in person what was claimed online.
  • You're inside a hospital. ICU on the same floor or adjacent floor. OR signage visible.
  • Your named physician shows up. Not a substitute. Not "the team."
  • IV set up by hospital nursing, not clinic staff. Vitals monitored throughout.
  • Receipt itemized to match the original quote. Variances explained.
After · T+7 onward
Continuity to your home system.
  • Day 7 check-in from the clinic. Phone or video.
  • Day 30 follow-up. Structured, not "let us know how you're doing."
  • You know who to call if something changes, a named person, not a generic inbox.
  • Month 3 and Month 12 on the calendar before you leave Mexico.
  • Lot records retained for 10+ years per regulator. Retrievable if your records request comes years later.
Honest 05?What we will not claim about ourselves

What the check says about us.

Applied to Celva, the five-layer check returns: yes, yes, yes, yes, yes. The infusions happen inside Hospital Angeles Tijuana (a internationally accredited hospital with ICU and OR on the same campus). The cells are our own proprietary product, manufactured under COFEPRIS-supervised cGMP at our lab inside Hospital Angeles with documented release testing, not bought from a third-party supplier. Named physicians are on staff with verifiable credentials (see §4.1). The SAE pathway is written and available on request. Our cost floor is structurally above the cost of doing the work.

What we will not claim is that "medical tourism is safe." That's the wrong statement because it averages across quadrants we have no business defending. The defensible claim is narrower: cell therapy at a internationally accredited hospital with in-house cGMP manufacturing and named physicians carries a base-rate complication profile statistically indistinguishable from comparable procedures done in U.S. hospitals. That sentence is the entire honest argument. Anything broader is overreach.

The structural claims we stand behind.

  • Setting: All infusions are conducted inside Hospital Angeles Tijuana. Not in a freestanding clinic or outpatient office. See §4.2.
  • Manufacturing: Cells are produced in our COFEPRIS-supervised cGMP facility. Lot release docs are part of your record. See §3.6.
  • Physicians: Named physicians, each with verifiable credentials, are involved in every patient's care. See §4.1.
  • SAE pathway: Written protocol covering admission rights, ICU coverage, evacuation, and U.S. continuity. Available before deposit. See §4.4.
  • Cost floor: Itemized quote provided after consult; no incentives to take a candidate who shouldn't be a candidate.
The bottom line

The question hides four questions. The quadrant is the unit.

Medical tourism's "safety" is not one number. A complex procedure at a internationally accredited hospital abroad carries a complication rate statistically indistinguishable from the same procedure done at home (~3%). The same procedure at an unaccredited facility runs 4× that. Almost every reported disaster traces to an unaccredited facility, an unregulated lab, no hospital backup, or aggressive discount marketing, all identifiable in advance. The five-layer check (hospital · cGMP · named physicians · written SAE pathway · cost floor) separates the defensible from the dangerous. Apply it to us. Apply it to anyone.